One of our newest research initiatives is an NIH-funded clinical trial testing the safety and efficacy of a drug called tofacitinib
Crnic Institute researchers’ discovery could lead to more effective COVID treatment with immune modulatory drugs
Our scientists, data analysts, and administrators have teamed up with Children's Hospital of Philadelphia and Sage Bionetworks for this new initiative
The Trial-Ready Cohort-Down Syndrome (TRC-DS) matches people with Down syndrome to clinical trials studying DS related Alzheimer’s disease.
Mother, scientist address challenges and share hope as collaborative study in research epicenter launches
As co-chair of the Senate Down Syndrome Caucus, Sen. Jerry Moran hosted a roundtable discussion on scientific advances in Down syndrome research and recent groundbreaking discoveries from the National Institutes of Health (NIH) INCLUDE Project.
Scientists and physicians have teamed up to identify effective treatments for persons suffering from Down Syndrome Regression Disorder (DSRD).
The funding will support biomedical research on a wide range of co-occurring conditions of Down syndrome.